FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783450169> ?p ?o ?g. }

• W2783450169 endingPage "1291" @default.
• W2783450169 startingPage "1275" @default.
• W2783450169 abstract "Measurable residual disease (MRD; previously termed minimal residual disease) is an independent, postdiagnosis, prognostic indicator in acute myeloid leukemia (AML) that is important for risk stratification and treatment planning, in conjunction with other well-established clinical, cytogenetic, and molecular data assessed at diagnosis. MRD can be evaluated using a variety of multiparameter flow cytometry and molecular protocols, but, to date, these approaches have not been qualitatively or quantitatively standardized, making their use in clinical practice challenging. The objective of this work was to identify key clinical and scientific issues in the measurement and application of MRD in AML, to achieve consensus on these issues, and to provide guidelines for the current and future use of MRD in clinical practice. The work was accomplished over 2 years, during 4 meetings by a specially designated MRD Working Party of the European LeukemiaNet. The group included 24 faculty with expertise in AML hematopathology, molecular diagnostics, clinical trials, and clinical medicine, from 19 institutions in Europe and the United States." @default.
• W2783450169 created "2018-01-26" @default.
• W2783450169 creator A5001967659 @default.
• W2783450169 creator A5006122560 @default.
• W2783450169 creator A5012863731 @default.
• W2783450169 creator A5013255815 @default.
• W2783450169 creator A5013626352 @default.
• W2783450169 creator A5013754928 @default.
• W2783450169 creator A5018416096 @default.
• W2783450169 creator A5018592613 @default.
• W2783450169 creator A5028452852 @default.
• W2783450169 creator A5028591457 @default.
• W2783450169 creator A5029157287 @default.
• W2783450169 creator A5043414993 @default.
• W2783450169 creator A5046387225 @default.
• W2783450169 creator A5048388170 @default.
• W2783450169 creator A5050125183 @default.
• W2783450169 creator A5053578678 @default.
• W2783450169 creator A5053983155 @default.
• W2783450169 creator A5054317101 @default.
• W2783450169 creator A5061303658 @default.
• W2783450169 creator A5068303471 @default.
• W2783450169 creator A5070729528 @default.
• W2783450169 creator A5075397421 @default.
• W2783450169 creator A5080912335 @default.
• W2783450169 creator A5089075443 @default.
• W2783450169 date "2018-03-22" @default.
• W2783450169 modified "2023-10-11" @default.
• W2783450169 title "Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party" @default.
• W2783450169 cites W1500412381 @default.
• W2783450169 cites W1513924279 @default.
• W2783450169 cites W1531493896 @default.
• W2783450169 cites W1880892126 @default.
• W2783450169 cites W1967685674 @default.
• W2783450169 cites W1977924848 @default.
• W2783450169 cites W1981462221 @default.
• W2783450169 cites W1984658294 @default.
• W2783450169 cites W1985823023 @default.
• W2783450169 cites W1992453745 @default.
• W2783450169 cites W1992656466 @default.
• W2783450169 cites W1992826811 @default.
• W2783450169 cites W1998812105 @default.
• W2783450169 cites W1999790790 @default.
• W2783450169 cites W2005410572 @default.
• W2783450169 cites W2006714444 @default.
• W2783450169 cites W2007302457 @default.
• W2783450169 cites W2011760482 @default.
• W2783450169 cites W2018380183 @default.
• W2783450169 cites W2020417052 @default.
• W2783450169 cites W2023267905 @default.
• W2783450169 cites W2028231895 @default.
• W2783450169 cites W2034653731 @default.
• W2783450169 cites W2036862498 @default.
• W2783450169 cites W2038242472 @default.
• W2783450169 cites W2055034746 @default.
• W2783450169 cites W2055521874 @default.
• W2783450169 cites W2060842588 @default.
• W2783450169 cites W2068208386 @default.
• W2783450169 cites W2071206691 @default.
• W2783450169 cites W2076031927 @default.
• W2783450169 cites W2078647570 @default.
• W2783450169 cites W2080104001 @default.
• W2783450169 cites W2082484676 @default.
• W2783450169 cites W2087296000 @default.
• W2783450169 cites W2087734794 @default.
• W2783450169 cites W2089596135 @default.
• W2783450169 cites W2090630520 @default.
• W2783450169 cites W2090932554 @default.
• W2783450169 cites W2097501404 @default.
• W2783450169 cites W2102327267 @default.
• W2783450169 cites W2104127840 @default.
• W2783450169 cites W2104411649 @default.
• W2783450169 cites W2118250079 @default.
• W2783450169 cites W2120204058 @default.
• W2783450169 cites W2123424761 @default.
• W2783450169 cites W2124159210 @default.
• W2783450169 cites W2126816979 @default.
• W2783450169 cites W2128541003 @default.
• W2783450169 cites W2129840793 @default.
• W2783450169 cites W2133262115 @default.
• W2783450169 cites W2135346203 @default.
• W2783450169 cites W2138265677 @default.
• W2783450169 cites W2141324982 @default.
• W2783450169 cites W2143197030 @default.
• W2783450169 cites W2144737390 @default.
• W2783450169 cites W2148965443 @default.
• W2783450169 cites W2149858388 @default.
• W2783450169 cites W2153382436 @default.
• W2783450169 cites W2153994826 @default.
• W2783450169 cites W2159875685 @default.
• W2783450169 cites W2162411731 @default.
• W2783450169 cites W2163358530 @default.
• W2783450169 cites W2163646556 @default.
• W2783450169 cites W2165388941 @default.
• W2783450169 cites W2168438358 @default.
• W2783450169 cites W2168480534 @default.
• W2783450169 cites W2169046713 @default.
• W2783450169 cites W2184458350 @default.

• next